Interleukin-6 secretion is limited by self-signaling in endosomes-Reference-Cited by-同舟云学术

Interleukin-6 secretion is limited by self-signaling in endosomes

Published:2018-07-16 Issue:2 Volume:11 Page:144-157
ISSN:1759-4685
Container-title:Journal of Molecular Cell Biology
language:en
Short-container-title:

Author:

Verboogen Daniëlle R J¹^ORCID,Revelo Natalia H¹,ter Beest Martin¹,van den Bogaart Geert¹²

Affiliation:

1. Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Molecular Immunology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, Groningen, The Netherlands

Funder

European Research Council

European Union’s Seventh Framework Programme

Radboud University Medical Center, a Career Development Award

Human Frontier Science Program

NWO Gravitation Programme

Netherlands Organization for Scientific Research

EMBO Long-Term Fellowship

NWO-ALW

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/jmcb/article-pdf/11/2/144/27989413/mjy038.pdf

Reference100 articles.

1. The R-SNARE endobrevin/VAMP-8 mediates homotypic fusion of early endosomes and late endosomes;Antonin;Mol. Biol. Cell,2000

2. Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum;Bergamaschi;Blood,2012

3. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity;Bergamaschi;J. Biol. Chem.,2008

4. Monocyte 15-lipoxygenase expression is regulated by a novel cytosolic signaling complex with protein kinase C and tyrosine-phosphorylated Stat3;Bhattacharjee;J. Immunol.,2006

5. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells;Black;Nature,1997

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID–19 patients treated with tocilizumab;Infection;2024-08-29

2. Classification of Congenital Leptin Deficiency;The Journal of Clinical Endocrinology & Metabolism;2024-03-12

3. Characterization of differences in immune responses during bolus and continuous infusion endotoxin challenges using mathematical modelling;Experimental Physiology;2024-03-11

4. Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure;Biochemical Pharmacology;2024-01

5. Harnessing PROTAC technology to combat stress hormone receptor activation;Nature Communications;2023-12-09